Findings could pave the way for more personalized treatments for cardiovascular disease.
High cholesterol is a health concern that often goes unnoticed due to its lack of symptoms, allowing it to silently increase ...
“We need global awareness of lipoprotein (a),” Tremulis tells Fortune. “High lipoprotein (a) impacts one in five globally…And ...
“The short answer to that is, since we have not had any medication to treat it, there has not been as much interest amongst ...
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which ...
NewAmsterdam Pharma reports Phase 3 trial success for obicetrapib, achieving significant LDL-C reduction in ASCVD and HeFH ...
Jefferies says Esperion (ESPR) shares have pulled back on competitor NewAmsterdam Pharma’s (NAMS) Phase III topline for its novel CETP ...
National Institute of Health (NIH) scientists have made a significant breakthrough in understanding how "bad" cholesterol, ...
Scientists have made a significant breakthrough in understanding how 'bad' cholesterol, known as low-density lipoprotein-cholesterol or LDL-C, builds up in the body. The researchers were able to show ...